Literature DB >> 33652920

Co-Administration of Gagam-Sipjeondaebo-Tang and Ibuprofen Alleviates the Inflammatory Response in MPTP-Induced Parkinson's Disease Mouse Model and RAW264.7 Macrophages.

Sodam Won1,2, Jade Heejae Ko1,2, Hayoung Jeon1,2, Seong-Sik Park3, Seung-Nam Kim1.   

Abstract

Parkinson's disease (PD), a common neurodegenerative disease, is characterized by degeneration of dopaminergic neurons with neuroinflammation. Gagam-Sipjeondaebo-Tang (GST), a traditional herbal formula made of twelve medicinal herbs, is known to be effective in PD, and the use of ibuprofen has been associated with a lower risk of PD. The aim of this study was to evaluate whether the combined administration of GST and ibuprofen affects the inflammatory response of Parkinson's disease. MPTP-induced parkinsonian mouse models were treated with GST or ibuprofen using oral gavage once a day for 5 days. The effects of GST were examined by measuring the TH level and expression of CD68 in the mice brain in addition to behavioral tests. The anti-inflammatory effect of GST on the LPS-treated RAW264.7 murine macrophages was examined using the NO assay. Inflammatory cytokines were analyzed using quantitative-PCR and flow cytometry. In the results, GST significantly improved the loss of dopaminergic neurons and alleviated PD-induced behavioral deficits. GST also decreased macrophage activation in the MPTP-induced PD mouse model. Interestingly, co-administration of GST and ibuprofen showed a synergistic effect in improving the loss of dopaminergic neurons and decreasing the activation of macrophages. Moreover, the NO level decreased in LPS-stimulated macrophages with this combined treatment. GST reduced iNOS, COX-2, IL-1β, and IL-6 levels, and co-administration with ibuprofen showed a synergistic effect. Furthermore, pretreatment of GST reduced the expression levels of MCP-1 and IL-12 p70 in LPS-stimulated RAW264.7 cells. These results can possibly suggest a future therapeutic approach for PD patients.

Entities:  

Keywords:  Gagam-Sipjeondaebo-Tang; Parkinson’s disease; herb; ibuprofen; neuroinflammation

Year:  2021        PMID: 33652920      PMCID: PMC7996732          DOI: 10.3390/pathogens10030268

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  48 in total

1.  NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Du-Chu Wu; Peter Teismann; Kim Tieu; Miquel Vila; Vernice Jackson-Lewis; Harry Ischiropoulos; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

2.  Deceptive curcumin offers cautionary tale for chemists.

Authors:  Monya Baker
Journal:  Nature       Date:  2017-01-11       Impact factor: 49.962

3.  [Preliminary sero-epidemiologic studies on arboviruses in selected occupational groups of the healthy population of the country].

Authors:  H Kicińska
Journal:  Przegl Epidemiol       Date:  1966

4.  Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's beta-amyloid proteins.

Authors:  Hironori Fujiwara; Koh Iwasaki; Katsutoshi Furukawa; Takashi Seki; Mei He; Masahiro Maruyama; Naoki Tomita; Yukitsuka Kudo; Makoto Higuchi; Takaomi C Saido; Sumihiro Maeda; Akihiko Takashima; Masahiko Hara; Yasushi Ohizumi; Hiroyuki Arai
Journal:  J Neurosci Res       Date:  2006-08-01       Impact factor: 4.164

5.  Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.

Authors:  Jin Sup Shim; Hyo Geun Kim; Mi Sun Ju; Jin Gyu Choi; Seo Young Jeong; Myung Sook Oh
Journal:  J Ethnopharmacol       Date:  2009-08-22       Impact factor: 4.360

Review 6.  Role of nitric oxide in inflammatory diseases.

Authors:  J N Sharma; A Al-Omran; S S Parvathy
Journal:  Inflammopharmacology       Date:  2007-12       Impact factor: 4.473

7.  Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.

Authors:  Lilia Marinova-Mutafchieva; Mona Sadeghian; Lauren Broom; John B Davis; Andrew D Medhurst; David T Dexter
Journal:  J Neurochem       Date:  2009-06-22       Impact factor: 5.372

Review 8.  Neuroinflammation in Parkinson's disease and its potential as therapeutic target.

Authors:  Qinqin Wang; Yingjun Liu; Jiawei Zhou
Journal:  Transl Neurodegener       Date:  2015-10-12       Impact factor: 8.014

Review 9.  Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration.

Authors:  Russell L Blaylock
Journal:  Surg Neurol Int       Date:  2017-04-26

Review 10.  Evaluation of Models of Parkinson's Disease.

Authors:  Shail A Jagmag; Naveen Tripathi; Sunil D Shukla; Sankar Maiti; Sukant Khurana
Journal:  Front Neurosci       Date:  2016-01-19       Impact factor: 4.677

View more
  1 in total

Review 1.  Evidence for Oxidative Pathways in the Pathogenesis of PD: Are Antioxidants Candidate Drugs to Ameliorate Disease Progression?

Authors:  Alexander Leathem; Tamara Ortiz-Cerda; Joanne M Dennis; Paul K Witting
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.